Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Improving Cognition and Negative Symptoms in Schizophrenia With N-Acetylcysteine: a Magnetic Resonance Spectroscopy Study of Glutamate and Glutathione

NCT02505477 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT02505477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02505477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Improving Cognition and Negative Symptoms in Schizophrenia With N-Acetylcysteine: a Magnetic Resonance Spectroscopy Study of Glutamate and Glutathione
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
February 6, 2017
Completion date
January 31, 2023
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive deficits, schizophrenia, schizophrenia; negative type